News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
595,526 Results
Type
Article (35782)
Company Profile (113)
Press Release (559631)
Section
Business (170987)
Career Advice (2697)
Deals (32235)
Drug Delivery (64)
Drug Development (71868)
Employer Resources (155)
FDA (15321)
Job Trends (14427)
News (297093)
Policy (28723)
Tag
Academia (2637)
Africa (748)
Alabama (33)
Allergies (39)
Alliances (42570)
Alzheimer's disease (1124)
Antibody-drug conjugate (ADC) (33)
Approvals (15268)
Arizona (84)
Artificial intelligence (39)
Asia (34869)
Australia (6195)
Bankruptcy (278)
Best Places to Work (11619)
Biosimilars (49)
C2C Services and Suppliers (62338)
California (836)
Canada (639)
Cancer (153)
Career advice (2233)
CAR-T (33)
Cell therapy (65)
China (39)
Clinical research (55794)
Collaboration (47)
Colorado (34)
COVID-19 (2327)
Cystic fibrosis (71)
Diabetes (30)
Diagnostics (6123)
Diversity, equity & inclusion (38)
Drug pricing (43)
Earnings (64276)
Employer resources (131)
Europe (80330)
Events (96498)
Executive appointments (27)
FDA (15363)
Florida (106)
Funding (28)
Gene therapy (48)
GLP-1 (383)
Government (3901)
Healthcare (19516)
Hotbed/Location (409530)
Idaho (56)
Illinois (188)
Indiana (109)
Infectious disease (2338)
Inflammatory bowel disease (88)
Interviews (534)
IPO (15767)
Job creations (2854)
Job search strategy (1877)
Kansas (88)
Layoffs (330)
Legal (6272)
Liver cancer (43)
Lung cancer (31)
Maine (52)
Management (52)
Manufacturing (35)
Maryland (242)
Massachusetts (458)
Medical device (13550)
Medtech (13553)
Mergers & acquisitions (16244)
Metabolic disorders (107)
Neuroscience (1195)
New Jersey (61)
New York (82)
NextGen Class of 2024 (6671)
Non-profit (4784)
North Carolina (175)
Obesity (62)
Opinion (176)
Parkinson's disease (30)
Patents (30)
Peanut (35)
Pennsylvania (55)
People (49778)
Phase I (17279)
Phase II (24783)
Phase III (18569)
Policy (32)
Postmarket research (1999)
Preclinical (7081)
Rare diseases (91)
Real estate (4856)
Recruiting (61)
Regulatory (19226)
Research institute (2418)
Resumes & cover letters (442)
South America (1070)
Startups (3011)
Texas (90)
United States (2986)
Vaccines (359)
Washington State (117)
Weight loss (51)
Date
Today (12)
Last 7 days (495)
Last 30 days (1783)
Last 365 days (39193)
2024 (22095)
2023 (41284)
2022 (52113)
2021 (57042)
2020 (55569)
2019 (48735)
2018 (36632)
2017 (32103)
2016 (30368)
2015 (35476)
2014 (24629)
2013 (19206)
2012 (20726)
2011 (21532)
2010 (18623)
595,526 Results for "biotage ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
Gyros Protein Technologies AB and Biotage announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean catch and release technology, on Biotage® Extrahera™ automated sample preparation system.
December 7, 2023
·
2 min read
Vitrolife AB (publ) completes the acquisition of eFertility
Vitrolife AB has completed the acquisition of eFertility as previously communicated in the press release on 2 May 2024.
May 22, 2024
·
1 min read
Number of shares and votes in Medivir AB on 28 June 2024
Medivir AB announces that the number of shares and votes in Medivir has changed during June 2024 as a result of the issue of 1,700,000 shares of series C and the reclassification of 114 587 shares of series C to ordinary shares which was carried out as a part of the implementation of the incentive program resolved by the general meeting on 7 May 2024.
June 28, 2024
·
2 min read
Business
Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader
Gamma Biosciences announced that it has entered into an agreement with Swedish life sciences company Biotage AB, whereby Biotage will acquire Gamma’s operating company, Astrea Bioseparations, in exchange for newly issued shares in Biotage, creating a global chromatography leader with an attractive mix of products and services across multiple end-markets globally.
February 15, 2023
·
5 min read
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science SA (Euronext - FR0010557264 - AB) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a trending toward a negative opinion on the application for conditional marketing authorisation of masitinib in the treatment of amyotrophic lateral sclerosis (ALS), following an oral explanation held at the 28 May meeting of the CHMP.
May 29, 2024
·
3 min read
Deals
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
The Board of Directors of Calliditas Therapeutics AB unanimously recommends that the shareholders and holders of American Depositary Shares of Calliditas Therapeutics AB accept the public tender offer by Asahi Kasei Corporation.
May 28, 2024
·
24 min read
Deals
Vitrolife AB (publ) acquires eFertility
Vitrolife AB signed an agreement to acquire 100% of the shares in eFertility. This acquisition is a key element of the Vitrolife Group’s strategy to bring increased standardisation and digitalisation to IVF clinics around the world.
May 2, 2024
·
2 min read
Business
AB Science reports its revenues for the year 2023 and provides an update on its activities
AB Science SA reports its revenues for the year 2023 and provides an update on its activities.
May 15, 2024
·
23 min read
Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB
IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Today, on Wednesday May 22, 2024, IRLAB Therapeutics AB held its Annual General Meeting.
May 22, 2024
·
7 min read
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
AB Science SA (Euronext - FR0010557264 - AB) today announced that the European patent office has issued a Grant Decision for a patent relating to methods of treating severe mastocytosis with its lead compound masitinib (patent EP 3359195A1).
May 13, 2024
·
5 min read
1 of 59,553
Next